Clinical Trials Directory

Trials / Unknown

UnknownNCT00221780

Role of Left Ventricular Pacing Site

Importance of Left Ventricular Pacing Site in Biventricular Resynchronization Therapy for Severe Heart Failure

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
33 (estimated)
Sponsor
University Hospital, Bordeaux · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cardiac resynchronization therapy has been shown to be effective in reducing symptoms and mortality in heart failure patients. However, very few is known about the importance of the left ventricular pacing site. We study in a random order 11 different left ventricular pacing sites and compare their hemodynamics using pressure-volume catheters. The consequences on the surface ECG are also assessed.

Detailed description

Background. Cardiac resynchronization therapy has been shown to be effective in reducing symptoms and mortality in heart failure patients. However, very few is known about the importance of the left ventricular pacing site. Design. Single-blind, monocentric, randomized cross-over study comparing 11 left ventricular pacing sites in a random order. Intervention. Left ventricular DDD pacing on 11 ventricular sites, prior to the implantation. At each pacing site, a control hemodynamics will be obtained in AAI pacing at the same pacing rate. At each pacing site, 2 AV delays, a short and a long one, will be assessed. Eligibility criteria. Patients referred for cardiac resynchronization therapy for heart failure Outcomes. Hemodynamic measures using pressure-volume catheters.

Conditions

Interventions

TypeNameDescription
DEVICEleft ventricular pacing

Timeline

Start date
2003-11-01
Completion
2007-12-01
First posted
2005-09-22
Last updated
2007-06-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00221780. Inclusion in this directory is not an endorsement.